LCM
BVS icon

Legato Capital Management’s Bioventus BVS Stock Holding History

Legato Capital Management’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.83M Buy
200,336
+62,774
+46% +$526K 0.17% 181
2025
Q4 		$1.02M Buy
137,562
+125,525
+1,043% +$902K 0.09% 350
2025
Q3 		$80.5K Hold
12,037
– – 0.01% 539
2025
Q2 		$79.7K Buy
+12,037
New +$85.4K 0.01% 538

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Legato Capital Management's BVS Position: Q1 2026 in Review

Legato Capital Management increased its Bioventus (BVS) stake by 46% in Q1 2026, buying an estimated $526K and bringing the position to 200,336 shares worth $1.83M. The position accounts for 0.17% of the portfolio, ranked #181.

Legato Capital Management first reported a position in BVS in Q2 2025 and has held it in 4 quarters since. 157 funds tracked by Wall St. Rank hold BVS as of Q1 2026.

  • Legato Capital Management held 200,336 shares of Bioventus worth $1.83M as of Q1 2026.
  • Legato Capital Management bought 62,774 Bioventus shares in Q1 2026, an estimated $526K.
  • Bioventus made up 0.17% of Legato Capital Management's portfolio in Q1 2026, its #181 holding.
  • Legato Capital Management first reported a position in Bioventus in Q2 2025 and has held it in 4 quarters since.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q1 2026.

Based on Legato Capital Management's 13F filing for Q1 2026, filed 14 May 2026.